Handok Market Cap ($71.66 Million)
Market Cap & Net Worth: Handok (002390)
Handok market cap. Handok (KO:002390) has a market capitalization of $71.66 Million (₩105.75 Billion) as of November 4, 2026. Listed on the KO stock exchange, this Korea-based company holds position #20324 globally and #1094 in its home market, demonstrating a -1.21% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Handok's stock price ₩8140.00 by its total outstanding shares 12990956 (12.99 Million). Also see Handok cash flow conversion for how efficiently the company converts equity into cash flow.
Handok Market Cap History (2015–2026)
Handok market cap history from 2015 to 2026. Data shows change from $236.21 Million to $71.66 Million (-8.54% CAGR). Check 002390 share price today for real-time trading data and today's change.
Handok Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Handok's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore net asset momentum of Handok to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.00x
Handok's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $212.28 Million | $396.13 Billion | -$6.45 Billion | 0.00x | N/A |
| 2017 | $269.26 Million | $417.97 Billion | $4.87 Billion | 0.00x | 0.06x |
| 2018 | $254.34 Million | $446.73 Billion | $7.99 Billion | 0.00x | 0.03x |
| 2019 | $189.97 Million | $473.00 Billion | $34.93 Billion | 0.00x | 0.01x |
| 2020 | $281.88 Million | $503.61 Billion | $26.96 Billion | 0.00x | 0.01x |
| 2021 | $196.02 Million | $517.64 Billion | $3.29 Billion | 0.00x | 0.06x |
| 2022 | $147.46 Million | $543.76 Billion | $10.68 Billion | 0.00x | 0.01x |
| 2023 | $125.89 Million | $522.74 Billion | -$28.80 Billion | 0.00x | N/A |
| 2024 | $106.09 Million | $507.36 Billion | -$52.56 Billion | 0.00x | N/A |
| 2025 | $98.60 Million | $535.14 Billion | -$2.15 Billion | 0.00x | N/A |
Competitor Companies of 002390 by Market Capitalization
Companies near Handok in the global market cap rankings as of November 4, 2026. Also see Handok asset portfolio for a full breakdown of the balance sheet.
Key companies related to Handok by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #509 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #534 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #580 globally with a market cap of $46.03 Billion USD ( CN¥314.55 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #618 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #509 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #534 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $45.90 |
| #580 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $46.03 Billion | CN¥49.31 |
| #618 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €18.50 |
Market Capitalization of Handok (2015–2026)
Market capitalization of Handok from 2015 to today. Between 2015 and today, Handok's market cap moved from $236.21 Million to $ 71.66 Million, with a yearly change of -8.54%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩71.66 Million | -27.32% |
| 2025 | ₩98.60 Million | -7.05% |
| 2024 | ₩106.09 Million | -15.73% |
| 2023 | ₩125.89 Million | -14.63% |
| 2022 | ₩147.46 Million | -24.77% |
| 2021 | ₩196.02 Million | -30.46% |
| 2020 | ₩281.88 Million | +48.38% |
| 2019 | ₩189.97 Million | -25.31% |
| 2018 | ₩254.34 Million | -5.54% |
| 2017 | ₩269.26 Million | +26.84% |
| 2016 | ₩212.28 Million | -10.13% |
| 2015 | ₩236.21 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of Handok was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $71.66 Million USD |
| MoneyControl | $71.66 Million USD |
| MarketWatch | $71.66 Million USD |
| marketcap.company | $71.66 Million USD |
| Reuters | $71.66 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Handok
HANDOK Inc. operates as a pharmaceutical company. The company provides prescription and OTC drugs; medical devices, such as blood pressure monitors, cholesterol monitoring systems, insulin pumps, self-monitoring system of blood glucose, and blood glucose monitoring system; in vitro diagnostic medical devices; as well as life science products. It also offers healthcare products comprising food sup… Read more